!
Educational Recap — Charts For Reference Only This page summarizes the concepts and process Matt covered on the live call. Charts below show real live price action from TradingView — they are provided for reference, not as our own trade calls. This page shows no entry/stop/target levels of our own; for live setups and alerts, follow Matt directly.
← Back to Recap Hub
Mr M Trades
Live Call Recap Mr M Trades
RECORDED · 19 AUG 2026 · 83 MIN Episode 013
SESSION RECAP · 19 AUG 2026

Yields Fell. The Rotation Started. Healthcare, Biotech, Energy — The Next Leaders Are Forming Now.

Wednesday was the rotation day. Treasury yields fell to ~5.1% — fueled by the U.S. Treasury doubling long-end buyback operations from $2B to $4B effective Sept 9 — and the market bounced hard, reversing the prior day's sell-off. Money rotated out of tech (QQQ pulling back) and into broader sectors: RSP showing strength, leading sectors Healthcare (XLV), Biotech, Life Sciences, Oil & Gas, Energy. Moderna's melanoma vaccine Phase 3 results sparked the healthcare leg. LLY got entered live on a Stage 2 breakout at ~$1270. The risk-management framework got codified: +5% → stop to breakeven. +10% → sell 50%. Re-entry on pullback to 8-day MA. Critical risk: oil at $91, with $92 as the tripwire. The rotation has a heartbeat. The leaders are forming. The discipline is the same.

Market Stance
ROTATION DAY · YIELDS FALLING
Leading Sectors
XLV · BIOTECH · ENERGY
Forward Gate
OIL $92 TRIPWIRE
⏱ Forward Catalyst
OIL · $92 WATCH
--
Days
--
Hrs
--
Min
$92 BREAK = MARKET SELLOFF SIGNAL · TREASURY BUYBACKS LIVE SEP 9

Section 1 · Market State

Rotation day · yields falling · broader sectors taking the lead
Live Call · 19 Aug 2026
10Y Yields

Falling To ~5.1%

MacroBOUNCE FUEL
Treasury Ops

Long-End Buybacks $2B → $4B

EffectiveSEP 9
RSP

Equal-Weight Strong

ReadBROAD PARTICIPATION
QQQ

Tech Pulling Back

ReadROTATING OUT
Oil

$91 · $92 Tripwire

RiskBREAK = SELLOFF
New Trade

LLY · Stage 2 Breakout

Entry~$1270 · SCALED TO 3/4
Healthcare Catalyst

MRNA · Melanoma Vaccine

NewsPHASE 3 POSITIVE
Exits

MU · SK Hynix · NBIS

RationalePRICE ACTION WEAKNESS
Holding

SNDK · Relative Strength

ReadMEMORY COHORT LEADER

Section 2 · The Rotation Day — Where The Next Leaders Are Forming

Yields falling · money rotating · new Stage 2 setups emerging

Yields Fell. Money Rotated. The Next Leaders Are Forming In Healthcare, Biotech, And Energy.

Wednesday was the rotation day. The primary driver: Treasury yields fell to ~5.1%, reversing yesterday's sell-off. The fuel: the U.S. Treasury is doubling long-end buyback operations from $2B to at least $4B effective Sept 9. That's a structural bid for duration — and it cascaded into a broad market bounce that reversed the prior session's damage. The rotation: money moving from tech (QQQ pulling back) to broader sectors (RSP showing strength).

The leading sectors on the day: Healthcare (XLV), Biotech, Life Sciences, Oil & Gas, and Energy. Moderna's Phase 3 positive results on a melanoma cancer vaccine sparked the healthcare leg — and that's where the new trade came in. LLY entered live on a Stage 2 breakout at ~$1270, scaled to a 3/4 position with an average price of ~$1263. The scaling strategy is the lesson: build the full position within a tight 4–5% window from entry to maintain a low average cost and a large profit cushion. The exits matched the discipline: MU failed the $1040 level, SK Hynix had a 14% reversal, NBIS gave back profit on a $4.5B convertible note offering. The thesis on memory is intact long-term, but price action is the ultimate signal. Respect the chart, not the conviction.

Section 3 · Catalyst Board

Gates shaping the week ahead
Catalyst 01

Oil $92 Tripwire

RiskBREAK ABOVE = MARKET SELLOFF
Catalyst 02

Treasury Buybacks Live

EffectiveSEP 9 · $4B LONG-END
Catalyst 03

Sector Scan · Stage 2

FocusXLV · BIOTECH · ENERGY

Today's Verdict

Wednesday was the rotation day and the trade matched it. Yields fell to ~5.1% on the U.S. Treasury's doubling of long-end buybacks ($2B → $4B effective Sept 9), and money rotated out of tech (QQQ pulling back) into broader sectors (RSP showing strength). The leading sectors: Healthcare (XLV), Biotech, Life Sciences, Oil & Gas, Energy. LLY entered live on a Stage 2 breakout at ~$1270, scaled to a 3/4 position with an average of ~$1263 — the scaling discipline is to build the full position within 4–5% from entry for a low avg cost. Moderna's Phase 3 melanoma vaccine sparked the healthcare leg. The exits matched the discipline: MU failed $1040, SK Hynix had a 14% reversal, NBIS gave back profit on a $4.5B convertible — respect the chart, not the conviction. The risk-management framework got codified: +5% → stop to breakeven. +10% → sell 50%. Re-entry on 8-day MA pullback. The critical risk: oil at $91, $92 is the tripwire. The rotation has a heartbeat. The next leaders are forming. The discipline is the same.

The Concepts

The pattern and the lesson behind each name discussed
Charts show live price only — no entry/stop/target of ours
LLY
The New Trade — Stage 2 Breakout + Scaling Discipline
New Long

Entered live at ~$1270 on a Stage 2 breakout driven by strong healthcare sector momentum. Scaled: 1/2 position initial, added to 3/4 with an average of ~$1263. The goal: build the full position within 4–5% from entry to maintain a low average cost and a large profit cushion. The lesson generalizes: scaling isn't averaging down — it's adding into strength. The first entry is the trigger, the add is the confirmation. Tight scaling windows give you the lowest cost basis before the move runs.

MRNA
The Catalyst — Melanoma Vaccine Phase 3
On Watch

Up on positive Phase 3 results for a melanoma cancer vaccine — the catalyst that sparked the healthcare leg of the rotation. Matt's framing: the catalyst doesn't create the trade — the catalyst creates the sector momentum. The trade is the Stage 2 breakout in the leading names within the sector. The lesson: use the catalyst to identify the sector, then scan for the leaders with clean breakouts. Don't chase the catalyst name itself — chase the rotation.

XLV
The Sector Leader — Healthcare Strength
Sector Watch

The healthcare ETF (XLV) leading the rotation. Matt's framing: "leading sectors" — Healthcare, Biotech, Life Sciences, Oil & Gas, Energy — get scanned for Stage 2 breakout setups. The lesson: the sector tells you where the money is flowing. The individual names within the sector tell you which trades to take. The trade is the name, the sector is the regime.

MU
The Exit — Failed $1040 Level
Exited

Exited due to price action weakness — Micron failed to hold the $1040 level. Matt's framing: the long-term thesis is intact, but price action is the ultimate signal. The lesson: the thesis doesn't override the chart. A broken level is a broken level. The exit honored the chart, not the conviction. Re-entry is a new decision when the price action confirms.

NBIS
The Exit — Convertible Note Offering
Exited

Exited, giving back some profit. The stock pulled back to its breakout level after announcing a $4.5B convertible note offering. The 20-day moving average is critical support — a break below it would be a bearish signal. Matt's framing: capital structure changes (convertibles, secondary offerings) change the chart. The breakout level you bought at isn't the same level anymore. The lesson: when a company raises capital in size, the technical setup resets. Re-entry is a new decision, not a continuation.

SNDK
The Memory Cohort Leader — Relative Strength
Holding

Held from prior exposure. SanDisk has shown stronger relative strength than the rest of the memory cohort. Matt's framing: when the sector weakens and one name holds up, that's the leadership candidate for the next leg of the rotation. The lesson: relative strength is the cleanest signal that the institutional money hasn't left. Position management is part of the same trade.

RSP
The Breadth Gauge — Equal-Weight Strong
Macro Watch

Equal-weight S&P (RSP) showing strength — the breadth gauge telling you the average stock is participating. Matt's framing: when RSP is strong while QQQ pulls back, the rotation is real — money is moving out of mega-cap tech into the broader market. The lesson: RSP vs. QQQ is the single best signal for whether the rally has breadth or is just mega-cap-led. The trade is the breadth, not the headline.

QQQ
The Rotation Source — Tech Pulling Back
Macro Watch

QQQ pulling back as money rotates out of tech. Matt's framing: the QQQ pullback is not a market weakness signal — it's a rotation signal. The money is moving out of mega-cap tech into broader sectors. The lesson: don't sell because the QQQ is weak. Read the rotation. If RSP is strong and QQQ is weak, the money is still in the market — it's just changing which names it owns.

Theme Pulse · Two Narratives

Yields falling · rotation in · risk framework codified

Narrative A · The Rotation Has A Heartbeat

XLV · Biotech · Energy leading · RSP breadth confirming

The rotation is real and the new leaders are forming. Treasury yields fell to ~5.1% on the U.S. Treasury's doubling of long-end buybacks ($2B → $4B effective Sept 9), and money rotated out of tech (QQQ pulling back) into broader sectors (RSP showing strength). Healthcare (XLV), Biotech, Life Sciences, Oil & Gas, and Energy are the leading sectors — each one gets scanned for Stage 2 breakout setups. LLY entered live at ~$1270 on a Stage 2 breakout, scaled to a 3/4 position with an average of ~$1263 — the scaling discipline (build full position within 4–5% from entry) gives you the lowest cost basis before the move runs. The lesson: the rotation has a heartbeat. The next leaders are forming. The trade is the name, the sector is the regime.

Evidence: LLY new long · MRNA Phase 3 catalyst · XLV leading · RSP breadth · Treasury buybacks Sep 9 · SNDK relative strength in memory.

Narrative B · The $92 Oil Tripwire

Oil $91 · $92 break = market sell-off · yields can reverse

The rotation has a heartbeat, but the macro has a tripwire. Oil at $91 — a sustained break above $92 would likely trigger a market sell-off by increasing costs across the economy. The Treasury buybacks are live Sep 9, but until then, yields can reverse on any hawkish Fed signal. The memory cohort got cut: MU failed $1040, SK Hynix had a 14% reversal, NBIS gave back profit on a $4.5B convertible note offering. The lesson: the rotation is real, but the tripwire is real. Monitor oil. The chart signals work while the macro cooperates — the day it doesn't, stand aside.

Evidence: Oil $91 · $92 tripwire · MU failed $1040 · SK Hynix 14% reversal · NBIS $4.5B convertible · yields can reverse pre-Sep 9 · QQQ pullback reading ambiguous until RSP confirms.

Discipline

The most important message from today's call
The priority · The non-negotiable

The Risk Framework: +5% To Breakeven. +10% Sell 50%. Re-Entry On 8-Day MA.

Process over the candle · discipline over the noise

"respect stops. Non-negotiable. Accept small losses to avoid large ones." Wednesday's central lesson got codified into a framework that every trade can use: +5% gain → move stop-loss to breakeven, creating a risk-free trade. +10% gain → sell 50% of the position, locking in profit and reducing exposure. Re-entry: if the stock pulls back to a key moving average (e.g., the 8-day) and consolidates, consider re-adding to the position. The framework is the same on every name, every timeframe, every regime.

The exits proved the framework. MU failed the $1040 level — exited on price action weakness despite the long-term thesis. SK Hynix had a 14% reversal — exited. NBIS gave back profit on a $4.5B convertible note offering — exited. The lesson: price action is the ultimate signal. The thesis doesn't override the chart. Respect the chart, not the conviction. And the re-entry is a new decision, not a continuation — when the price action confirms, you can add back.

The scaling discipline on LLY is the other half. 1/2 position initial entry → add to 3/4 with an average of ~$1263 → goal: build the full position within 4–5% from entry. The math: tight scaling windows give you the lowest cost basis before the move runs. The first entry is the trigger, the add is the confirmation. The tripwire on the macro: oil at $91 — a sustained break above $92 triggers a market sell-off. Process over the candle. The rotation has a heartbeat. The discipline is the same.

Pre-Trade Checklist

Five checks. Every time. No exceptions.
Saved on this device
Risk defined? Stop loss is set before the entry. The number is written down.
Position sized? Size matches the stop. The trade can be wrong without damaging the account.
Key level identified? The trigger (breakout, reclaim, support hold) is clear and unambiguous.
Confirmation present? Setup isn't chasing. Structure is doing the work — base, reclaim, trigger.
Thesis documented? Why this trade, why now, what proves it right, what proves it wrong. One line each.
Exit plan ready? Targets are listed in order. Invalidation is named. Both are written before entry.
Why this matters: A great setup with bad sizing becomes a great loss. A mediocre setup with perfect sizing becomes a small win. The size is the trade — and that math is yours to do, on your own numbers, in your own broker.
Saved